1. Home
  2. SONM vs IMNN Comparison

SONM vs IMNN Comparison

Compare SONM & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • IMNN
  • Stock Information
  • Founded
  • SONM 1999
  • IMNN 1982
  • Country
  • SONM United States
  • IMNN United States
  • Employees
  • SONM N/A
  • IMNN N/A
  • Industry
  • SONM Telecommunications Equipment
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • IMNN Health Care
  • Exchange
  • SONM Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • SONM 10.2M
  • IMNN 12.1M
  • IPO Year
  • SONM 2019
  • IMNN 1985
  • Fundamental
  • Price
  • SONM $0.95
  • IMNN $0.60
  • Analyst Decision
  • SONM
  • IMNN Strong Buy
  • Analyst Count
  • SONM 0
  • IMNN 2
  • Target Price
  • SONM N/A
  • IMNN $15.50
  • AVG Volume (30 Days)
  • SONM 150.3K
  • IMNN 237.6K
  • Earning Date
  • SONM 05-12-2025
  • IMNN 05-12-2025
  • Dividend Yield
  • SONM N/A
  • IMNN N/A
  • EPS Growth
  • SONM N/A
  • IMNN N/A
  • EPS
  • SONM N/A
  • IMNN N/A
  • Revenue
  • SONM $58,243,000.00
  • IMNN N/A
  • Revenue This Year
  • SONM $127.68
  • IMNN N/A
  • Revenue Next Year
  • SONM N/A
  • IMNN N/A
  • P/E Ratio
  • SONM N/A
  • IMNN N/A
  • Revenue Growth
  • SONM N/A
  • IMNN N/A
  • 52 Week Low
  • SONM $1.03
  • IMNN $0.64
  • 52 Week High
  • SONM $10.70
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • SONM 29.91
  • IMNN 24.71
  • Support Level
  • SONM $1.31
  • IMNN $0.60
  • Resistance Level
  • SONM $1.50
  • IMNN $1.08
  • Average True Range (ATR)
  • SONM 0.15
  • IMNN 0.08
  • MACD
  • SONM -0.03
  • IMNN -0.02
  • Stochastic Oscillator
  • SONM 4.17
  • IMNN 3.12

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: